Arbutus Biopharma Corporation (LON:0SGC)
London · Delayed Price · Currency is GBP · Price in USD 3.319
+0.010 (0.30%)
At close: Jan 31, 2025
Arbutus Biopharma Market Cap
Arbutus Biopharma has a market cap or net worth of 604.51 million as of September 19, 2025. Its market cap has increased by 2.94% in one year.
Market Cap
604.51M
Enterprise Value
535.44M
Revenue
11.25M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.32
Market Cap Chart
Since November 15, 2010, Arbutus Biopharma's market cap has increased from 45.31M to 604.51M, an increase of 1,234.07%. That is a compound annual growth rate of 19.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 19, 2025 | 604.51M | 22.14% |
| Dec 31, 2024 | 494.95M | 50.38% |
| Dec 29, 2023 | 329.14M | 8.78% |
| Dec 30, 2022 | 302.57M | -22.14% |
| Dec 31, 2021 | 388.61M | 76.02% |
| Dec 31, 2020 | 220.78M | 69.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HSBC Holdings | 175.58B |
| AstraZeneca | 174.42B |
| Shell | 152.74B |
| Unilever | 113.28B |
| Rolls-Royce Holdings | 94.82B |
| British American Tobacco p.l.c. | 88.71B |
| Rio Tinto Group | 78.26B |
| BP p.l.c. | 65.73B |